Financial Results
Cairo Pharmaceuticals (CPCI.CA) Reports Year Ended 30/06/2026 Results
Published at 22 September 2026 at 12:33Cairo PharmaceuticalsRelated stock:Cairo Pharmaceuticals stockAll Cairo Pharmaceuticals disclosures
Disclosure summary
Company Name : Cairo Pharmaceuticals
ISIN Code : EGS38391C016
Currency : EGP
F/S Period : From 01/07/2025 To 30/06/2026
Net Profit : 552,540,334
F/S Period: From 01/07/2024 To 30/06/2025
Net Comparative Profit : 443,721,265
Audit Status : Audited
Source : Cairo Pharmaceuticals
The Sustainability Report (4,002 KB)
ISIN Code : EGS38391C016
Currency : EGP
F/S Period : From 01/07/2025 To 30/06/2026
Net Profit : 552,540,334
F/S Period: From 01/07/2024 To 30/06/2025
Net Comparative Profit : 443,721,265
Audit Status : Audited
Source : Cairo Pharmaceuticals
The Sustainability Report (4,002 KB)